GILL DAVID N
CIK: 0001106519
Director
Primary company: Y-mAbs Therapeutics, Inc. (YMAB)
GILL DAVID N is a corporate insider at Y-mAbs Therapeutics, Inc. (YMAB) filing SEC Form 4 transactions. 117 transactions across 11 companies, totaling $210,485 in purchases and $1,493,359 in sales. Source: SEC EDGAR.
Companies
Transaction History
Source: SEC EDGAR Form 4 insider transaction filings.
Company | Type | Shares | Price | Value | Shares After | Date | SEC |
|---|---|---|---|---|---|---|---|
Evolus, Inc. EOLS | Award | 45,559 | - | - | 86,887 | 2/17/2026 Filed: 2/17/2026 | Filing → |
Y-mAbs Therapeutics, Inc. YMAB | Disposition | 33,450 | - | - | 0 | 9/16/2025 Filed: 9/18/2025 | Filing → |
Y-mAbs Therapeutics, Inc. YMAB | Disposition | 14,545 | - | - | 0 | 9/16/2025 Filed: 9/18/2025 | Filing → |
Y-mAbs Therapeutics, Inc. YMAB | Disposition | 13,950 | - | - | 0 | 9/16/2025 Filed: 9/18/2025 | Filing → |
Y-mAbs Therapeutics, Inc. YMAB | Disposition | 16,000 | - | - | 0 | 9/16/2025 Filed: 9/18/2025 | Filing → |
Y-mAbs Therapeutics, Inc. YMAB | Disposition | 11,000 | - | - | 0 | 9/16/2025 Filed: 9/18/2025 | Filing → |
Y-mAbs Therapeutics, Inc. YMAB | Disposition | 11,000 | - | - | 0 | 9/16/2025 Filed: 9/18/2025 | Filing → |
Y-mAbs Therapeutics, Inc. YMAB | Disposition | 16,000 | - | - | 0 | 9/16/2025 Filed: 9/18/2025 | Filing → |
Y-mAbs Therapeutics, Inc. YMAB | Disposition | 24,000 | - | - | 0 | 9/16/2025 Filed: 9/18/2025 | Filing → |
Y-mAbs Therapeutics, Inc. YMAB | Disposition | 25,080 | - | - | 0 | 9/16/2025 Filed: 9/18/2025 | Filing → |
Y-mAbs Therapeutics, Inc. YMAB | Disposition | 5,825 | $8.60 | $50K | 0 | 9/16/2025 Filed: 9/18/2025 | Filing → |
Y-mAbs Therapeutics, Inc. YMAB | Award | 33,450 | - | - | 33,450 | 6/30/2025 Filed: 7/2/2025 | Filing → |
Y-mAbs Therapeutics, Inc. YMAB | Award | 25,080 | - | - | 30,905 | 6/30/2025 Filed: 7/2/2025 | Filing → |
Evolus, Inc. EOLS | Award | 11,146 | $13.58 | $151K | 11,146 | 3/7/2025 Filed: 3/11/2025 | Filing → |
Evolus, Inc. EOLS | Award | 7,364 | - | - | 41,328 | 3/7/2025 Filed: 3/11/2025 | Filing → |
Y-mAbs Therapeutics, Inc. YMAB | Award | 14,545 | - | - | 14,545 | 6/11/2024 Filed: 6/13/2024 | Filing → |
Y-mAbs Therapeutics, Inc. YMAB | Award | 3,495 | - | - | 5,825 | 6/11/2024 Filed: 6/13/2024 | Filing → |
Evolus, Inc. EOLS | Sale | 6,718 | $12.60 | $85K | 33,964 | 5/14/2024 Filed: 5/15/2024 | Filing → |
Evolus, Inc. EOLS | Sale | 3,643 | $12.72 | $46K | 40,682 | 5/13/2024 Filed: 5/15/2024 | Filing → |
Evolus, Inc. EOLS | Award | 9,377 | - | - | 9,377 | 2/7/2024 Filed: 2/9/2024 | Filing → |
Evolus, Inc.
EOLS
Type
Award
Shares
45,559
Price
-
Value
-
Y-mAbs Therapeutics, Inc.
YMAB
Type
Disposition
Shares
33,450
Price
-
Value
-
Y-mAbs Therapeutics, Inc.
YMAB
Type
Disposition
Shares
14,545
Price
-
Value
-
Y-mAbs Therapeutics, Inc.
YMAB
Type
Disposition
Shares
13,950
Price
-
Value
-
Y-mAbs Therapeutics, Inc.
YMAB
Type
Disposition
Shares
16,000
Price
-
Value
-
Y-mAbs Therapeutics, Inc.
YMAB
Type
Disposition
Shares
11,000
Price
-
Value
-
Y-mAbs Therapeutics, Inc.
YMAB
Type
Disposition
Shares
11,000
Price
-
Value
-
Y-mAbs Therapeutics, Inc.
YMAB
Type
Disposition
Shares
16,000
Price
-
Value
-
Y-mAbs Therapeutics, Inc.
YMAB
Type
Disposition
Shares
24,000
Price
-
Value
-
Y-mAbs Therapeutics, Inc.
YMAB
Type
Disposition
Shares
25,080
Price
-
Value
-
Y-mAbs Therapeutics, Inc.
YMAB
Type
Disposition
Shares
5,825
Price
$8.60
Value
$50K
Y-mAbs Therapeutics, Inc.
YMAB
Type
Award
Shares
33,450
Price
-
Value
-
Y-mAbs Therapeutics, Inc.
YMAB
Type
Award
Shares
25,080
Price
-
Value
-
Evolus, Inc.
EOLS
Type
Award
Shares
11,146
Price
$13.58
Value
$151K
Evolus, Inc.
EOLS
Type
Award
Shares
7,364
Price
-
Value
-
Y-mAbs Therapeutics, Inc.
YMAB
Type
Award
Shares
14,545
Price
-
Value
-
Y-mAbs Therapeutics, Inc.
YMAB
Type
Award
Shares
3,495
Price
-
Value
-
Evolus, Inc.
EOLS
Type
Sale
Shares
6,718
Price
$12.60
Value
$85K
Evolus, Inc.
EOLS
Type
Sale
Shares
3,643
Price
$12.72
Value
$46K
Evolus, Inc.
EOLS
Type
Award
Shares
9,377
Price
-
Value
-
AI Agent
Try asking...